- NXTC Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
NextCure (NXTC) S-1/AIPO registration (amended)
Filed: 29 Apr 19, 6:08am
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 5, 2019 (except for the seventh paragraph of Note 1 to the financial statements, as to which the date is , 2019), in Amendment 1 to the Registration Statement (Form S-1 No. 333-230837) and related Prospectus of NextCure, Inc. for the registration of 5,000,000 shares of its common stock.
Ernst & Young LLP
Tysons, VA
The foregoing consent is in the form that will be signed upon the completion of the reverse stock split described in the seventh paragraph of Note 1 to the financial statements.
/s/ Ernst & Young LLP
Tysons, VA
April 29, 2019
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.